⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL890216 | 0.76 | — | — | |
| SCHEMBL11033825 | 0.75 | GAA (0.51) | — | |
| SCHEMBL9016443 | 0.75 | TP53 (0.42) | — | |
| SCHEMBL1664386 | 0.73 | — | — | |
| 4-Imidazolecarboxylic Acid SCHEMBL317725 | 0.73 | — | — | |
| SCHEMBL826324 | 0.71 | — | — | |
| 4-Imidazolecarboxylic Acid SCHEMBL27484959 | 0.71 | — | — | |
| 4-Imidazolecarboxylic Acid SCHEMBL27315802 | 0.71 | — | — | |
| SCHEMBL5062922 | 0.71 | — | — | |
| 4-Imidazolecarboxylic Acid SCHEMBL27473022 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9676802-B2 | Hepatitis C virus inhibitors | ENANTA PHARMACEUTICALS, INC. (US) | 2017-06-13 | — | — | US | disclosed |
| EP-0748315-A1 | USE OF IMIDAZOLE DERIVATIVES FOR TREATING DISORDERS INVOLVING ANGIOTENSIN RECEPTORS AT 1? AND AT 2?, CERTAIN SUCH PRODUCTS, PREPARATION THEREOF, USE THEREOF AS DRUGS, AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME | ROUSSEL UCLAF (FR) | 1996-12-18 | — | — | EP | disclosed |